| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.63 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |